XUND funding news – Vienna-based HealthTech Scaleup XUND Secures €6 Million in Pre-Series A Round Funding

With new funding and an increasingly comprehensive portfolio of MDR-certified SaMD solutions, it is further strengthening its position as a homegrown European champion in digital health technology. With demand for AI-powered medical devices surging across the continent, XUND is well-positioned for rapid growth.

Over the coming months, the company will accelerate its expansion in DACH and the UK, leveraging its MDR-certified technology to enable digital interactions from prevention to diagnosis.

Read also - EcoDataCenter funding news – EcoDataCenter Secures €450 Million in Funding

The investment round was led by Lead Ventures and joined by J&T Ventures, with continued support from existing investors MassMutual Ventures, tba network, and LANA Ventures, who reaffirmed their commitment to XUND’s mission and growth trajectory.

Balázs Haszonics, Managing Partner at Lead Ventures said, “We are thrilled to partner with XUND, a company that brings clarity to the most important decisions in healthcare. Their commitment to digitizing the patient journey not only enhances patient care but also streamlines operations for healthcare providers. The long-anticipated synthesis of AI technology in patient care is finally happening widely and it is truly exciting to bring down the walls between new technologies and legacy healthcare systems. We have immense confidence in XUND's team and vision, and are eager to support their bold expansion efforts to transform healthcare delivery.”

David Polach, Partner at J&T Ventures: “The future of healthcare is not just digital — it’s intelligent, seamless, and deeply integrated. Our investment in XUND is driven by the thesis that AI-powered SaMD solutions will be the foundation of a more efficient, accessible, and data-driven healthcare system. What sets XUND apart is not only its world-class technology and the trust it has earned from some of the biggest names in healthcare but also the strength of its founding team and their bold vision. Their deep expertise, relentless execution, and commitment to transforming digital health give us full confidence that XUND is poised to become a global leader, redefining the future of healthcare at scale.”

At the same time, it is consolidating its role as a critical infrastructure provider in Europe's evolving healthcare landscape — fully aligned with the EU's latest InvestAI initiative, which plans to mobilize 200 billion euros for investment in AI solutions that strengthen technological sovereignty. As Europe continues to advance its leadership in AI-driven healthcare, XUND is well-positioned to play a key role in shaping this transformation.

Tamás Petrovics, Co-Founder and CEO of XUND: “The latest investment is a testimony to the hard work of our team over the past years. It will help us accelerate our expansion across Europe while advancing the integration of our medical devices and RAVE, our cutting-edge large language model (LLM) solution. We are laying the foundation for a data-driven, personalized healthcare system that redefines how care is delivered — today and tomorrow.”

About XUND

Founded in Vienna in 2018, the healthtech scale-up XUND specializes in developing Software as a Medical Device (SaMD), enabling digital interactions from prevention to diagnosis. With the vision of bringing clarity to the most important decisions in healthcare, it’s products are already used by leading insurers, hospitals, and pharmaceutical companies as the first digital point of contact. Today, the company employs more than 40 people across its locations in Vienna, Budapest, and London.